ADCY10 and cancer: Accumulated evidence suggests that the SAC machinery is responsible for the sensitivity of cancer cells to antimitotic agents12, 13, 14, 15, although the SAC mechanism is attenuated in a broad spectrum of primary tumours (Figs 8 and 9)48, 49, 50.